Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Supplement combo shows promise for metabolic health in small study

NCT ID NCT06486077

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a dietary supplement program called Power Line in 17 adults with a BMI between 28 and 35. The program includes a meal replacement shake, a green drink, a vascular health product, and a pre-meal fiber supplement. The main goal was to check safety and tolerability, while also looking at effects on blood sugar and cholesterol levels.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Power Line Program (meal replacement shake, green drink, vascular health product, pre-meal fiber supplement)
What this could lead to
If it works, this could point toward a dietary supplement approach to help manage markers of metabolic health like blood sugar and cholesterol.
What could go wrong
This is a very small, early-stage study with only 17 participants, so results may not apply to everyone. The main goal was safety, not proof of effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

17 people

The number who actually took part.

Started

May 2025

Finished

Nov 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 64 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Generally healthy Female, Male and Non-Binary adults, 18-64 years of age (Inclusive) Body Mass Index (BMI): 28.0-34.9 kilograms/meters2 (kg/m2) (Inclusive) Preference given to individuals having a minimum of two of the following markers of metabolic imbalance: fasting blood glucose ≥ 100 milligrams/deciliter (mg/dl), serum triglycerides (TG) \>100 mg/dl, serum high density lipoprotein - cholesterol (HDLc) (male sex \< 40 mg/dl, female sex \< 50 mg/dl), elevated blood pressure (systolic ≥ 120 and /or diastolic ≥ 80), elevated waist circumference (male sex ≥ 40 inches, female sex ≥ 35 inches) Willing to maintain a consistent diet (including medications, vitamins, and supplements) and lifestyle routine throughout the study. Willing to give written informed consent to participate in the Study. Exclusion Criteria: A serious, unstable illness including cardiac, hepatic, renal, gastrointestinal, respiratory, endocrinologic, neurologic, immunologic/rheumatological, or oncological/hematologic disease. Allergies related to ingredients in study products Known infection with HIV, TB or Hepatitis B or C. POCBP: Not using effective contraception. Blood Pressure medications or supplements Diabetes medications or supplements Cholesterol/Triglyceride lowering medications or supplements Currently taking nutritional supplements judged by the study coordinator to negate or camouflage the effects of the study products Use of Narcotics during the last 30 days Use of Anticoagulants during last 30 days Use of Corticosteroids during the last 30 days Use of controlled substances on a recreational basis during the last 30 days. Consumption of more than 3 alcoholic beverages per day. One beverage is a 5-ounce glass of wine, 12 ounces of beer, or one ounce of hard liquor. Inability to comply with Study and/or follow-up visits. Any concurrent condition (including clinically significant abnormalities in medical history, physical examination, or laboratory evaluations) which, in the opinion of the PI, would preclude safe participation in this study or interfere with compliance. Any sound medical, psychiatric, and/or social reason which, in the opinion of the PI, would preclude safe participation in this Study or interfere with compliance. \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Hughes Center for Research and Innovation

    Lehi, Utah, 84043, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.